Barone, E., Mancuso, C., Di Domenico, F., Sultana, R., Murphy, M., Head, E., & Butterfield, D. (2012). Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. Journal of Neurochemistry, 120(1), 135-46. https://doi.org/10.1111/j.1471-4159.2011.07538.x

Duncan, M., Guerriero, L., Köhler, K., Beechem, L., Gillis, B., Salisbury, F., … Murphy, M. (2022). Chronic Fragmentation of the Daily Sleep-Wake Rhythm Increases Amyloid-beta Levels and Neuroinflammation in the 3xTg-AD Mouse Model of Alzheimer’s Disease. Neuroscience, 481, 111-122. https://doi.org/10.1016/j.neuroscience.2021.11.042 (Original work published 2022)

Malec, J., Salisbury, D., Anders, D., Dennis, L., Groff, A., Johnson, M., … Smith, G. (2021). Response to the COVID-19 Pandemic Among Posthospital Brain Injury Rehabilitation Providers. Archives of Physical Medicine and Rehabilitation, 102(3), 549-555. https://doi.org/10.1016/j.apmr.2020.10.137

Weidner, A., Bradley, M., Beckett, T., Niedowicz, D., Dowling, A., Matveev, S., … Murphy, M. RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer’s disease. PloS One, 6(9), e24930. https://doi.org/10.1371/journal.pone.0024930 (Original work published 2011)

Sompol, P., Furman, J., Pleiss, M., Kraner, S., Artiushin, I., , … Norris, C. (2017). Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 37(25), 6132-6148. https://doi.org/10.1523/JNEUROSCI.0877-17.2017 (Original work published 2017)

Bradley-Whitman, M., Timmons, M., Beckett, T., Murphy, M., Lynn, B., & Lovell, M. (2014). Nucleic acid oxidation: an early feature of Alzheimer’s disease. Journal of Neurochemistry, 128(2), 294-304. https://doi.org/10.1111/jnc.12444

Lovell, M., Lynn, B., Fister, S., Bradley-Whitman, M., Murphy, M., Beckett, T., & Norris, C. (2016). A Novel Small Molecule Modulator of Amyloid Pathology. Journal of Alzheimer’s Disease : JAD, 53(1), 273-87. https://doi.org/10.3233/JAD-151160 (Original work published 2016)

Lange, M. B., St Clair, D., Markesbery, W., Studzinski, C., Murphy, M., & Butterfield, D. (2010). Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease. Neurobiology of Disease, 38(1), 104-15. https://doi.org/10.1016/j.nbd.2010.01.004

Aluise, C., Robinson, R., Beckett, T., Murphy, M., Cai, J., Pierce, W., … Butterfield, D. (2010). Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiology of Disease, 39(2), 221-8. https://doi.org/10.1016/j.nbd.2010.04.011

Butterfield, D., Barone, E., Di Domenico, F., Cenini, G., Sultana, R., Murphy, M., … Head, E. (2012). Atorvastatin treatment in a dog preclinical model of Alzheimer’s disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain. The International Journal of Neuropsychopharmacology, 15(7), 981-7. https://doi.org/10.1017/S1461145711001118